全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

肝细胞癌分级与动脉血供的相关性研究
The Relationship between the Grade of Hepatocellular Carcinoma and Arterial Blood Supply

DOI: 10.12677/jcpm.2024.31020, PP. 129-134

Keywords: 肝细胞癌,CT,血流管理学,血管成像
Hepatocellular Carcinoma
, CT, Hemodynamics, Vascular Imaging

Full-Text   Cite this paper   Add to My Lib

Abstract:

肝细胞癌(HCC)是世界上最常见的恶性肿瘤之一。影像学的最新进展使研究人员能够使用CT等工具评估肝细胞病变,尤其是发育不良结节或早期HCC的血流动力学。在肝癌进展过程中,大多数肝细胞结节在门脉血流丧失之前表现出动脉血流的恶化。随后,由于新生血管化动脉的显著增加,动脉血流成为主导。随着肿瘤的进展,门静脉血流量减少,最终肿瘤主要由动脉血供。再生结节、发育不良结节和分化良好的HCC中结节内血液供应的变化已被充分描述。本研究的目的是阐明肝细胞癌发生发展过程中动脉血供的时序性变化,重点是晚期HCC。
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The latest advances in imaging enable researchers to use tools such as CT to evaluate the hemodynamics of hepatocytic lesions, especially dysplastic nodules or early HCC. During the progression of hepatocellular carcinoma, most hepatocyte nodules show deterioration of arterial blood flow before the loss of portal blood flow. Subsequently, due to the significant increase of neovascularization artery, arterial blood flow became dominant. With the development of the tumor, the blood flow of the portal vein decreases, and finally the tumor is mainly supplied by the artery. The changes of blood supply in regenerated nodules, dysplastic nodules and well-differentiated HCC nodules have been fully described. The purpose of this study was to clarify the sequential changes of arterial blood supply during the occurrence and development of hepatocellular carcinoma, with emphasis on advanced HCC.

References

[1]  Okuda, K. (1997) Hepatocellular Carcinoma: Clinicopathological Aspects. Journal of Gastroenterology and Hepatology, 12, S314-S318.
https://doi.org/10.1111/j.1440-1746.1997.tb00515.x
[2]  EI-Serag, H.B. (2002) Hepatocellular Carcinoma: An Epidemiologic View. Journal of Clinical Gastroenterology, 35, S72-S78.
https://doi.org/10.1097/00004836-200211002-00002
[3]  Agarwal, A. and Jain, M. (2008) Multidetector CT Portal Venography in Evaluation of Portosystemic Collateral Vessels. Journal of Medical Imaging and Radiation Oncology, 52, 4-9.
https://doi.org/10.1111/j.1440-1673.2007.01903.x
[4]  Yoon, S.H., Lee, J.M., So, Y.H., et al. (2009) Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller than 3 Cm in Diameter: Tumor Size and Cellular Differentiation. AJR American Journal of Roentgenology, 193, W482-W489.
https://doi.org/10.2214/AJR.08.1818
[5]  Hayashi, M., Matsui, O., Ueda, K., et al. (1999) Correlation between the Blood Supply and Grade of Malignancy of Hepatocellular Nodules Associated with Liver Cirrhosis: Evaluation by CT during Intraarterial Injection of Contrast Medium. AJR American Journal of Roentgenology, 172, 969-976.
https://doi.org/10.2214/ajr.172.4.10587130
[6]  Nakajima, Y., Shimamura, T., Kamiyama, T., et al. (1996) Evaluation of Surgical Resection for Small Hepatocellular Carcinomas. The American Journal of Surgery, 171, 360-363.
https://doi.org/10.1016/S0002-9610(97)89642-0
[7]  Jonas, S., Bechstein, W.O., Steinmuller, T., et al. (2001) Vascular Invasion and Histopathologic Grading Determine Outcome after Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis. Hepatology, 33, 1080-1086.
https://doi.org/10.1053/jhep.2001.23561
[8]  Yu, J.S., Lee, J.H., Chung, J.J., et al. (2008) Small Hypervascular Hepatocellular Carcinoma: Limited Value of Portal and Delayed Phases on Dynamic Magnetic Resonance Imaging. Acta Radiologica, 49, 735-743.
https://doi.org/10.1080/02841850802120045
[9]  The Liver Cancer Study Group of Japan (2008) The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 5th Edition, Kanahara, Tokyo, 38-48. (In Japanese)
[10]  Song, X., Kelley, R.K., Khan, A.A., et al. (2023) Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma. Clinical Cancer Research, 29, 754-763.
https://doi.org/10.1158/1078-0432.CCR-22-1983
[11]  Mathieu, D., Grenier, P., Larde, D., et al. (1984) Portal Vein Involvement in Hepatocellular Carcinoma: Dynamic CT Features. Radiology, 152, 127-132.
https://doi.org/10.1148/radiology.152.1.6328574
[12]  Lim, J.H., Choi, D., Park, C.K., et al. (2006) Encapsulated Hepatocellular Carcinoma: CT-Pathologic Correlations. European Radiology, 16, 2326-2333.
https://doi.org/10.1007/s00330-006-0203-8
[13]  杨传红. CT能谱成像在肝细胞癌与肝转移瘤鉴别中的价值研究[D]: [硕士学位论文]. 济南: 山东大学, 2014.
[14]  Jang, H.J., Kim, T.K., Burns, P.N., et al. (2007) Enhancement Patterns of Hepatocellular Carcinoma at Contrast-Enhanced US: Comparison with Histologic Differentiation. Radiology, 244, 898-906.
https://doi.org/10.1148/radiol.2443061520
[15]  Edmondson, H.A. and Steiner, P.E. (1954) Primaty Carcinoma of the Liver: A Study of 100 Cases among 48,900 Necropsies. Cancer, 7, 462-503.
https://doi.org/10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
[16]  Okamoto, D., Yoshimitsu, K., Nishie, A., et al. (2012) Enhancement Pattern Analysis of Hypervascular Hepatocellular Carcinoma on Dynamic MR Imaging with Histopathological Correlation: Validity of Portal Phase Imaging for Predicting Tumor Grade. European Journal of Radiology, 81, 1116-1121.
https://doi.org/10.1016/j.ejrad.2011.02.056
[17]  Sutera, S.P. and Skalak, R. (1993) The History of Poiseuille’s Law. Annual Review of Fluid Mechanics, 25, 1-20.
https://doi.org/10.1146/annurev.fl.25.010193.000245
[18]  Kansaibougan, O.M., et al. (1991) Toriatsukai Kiyaku Ni Sotta Shuyou Kanbetsu Shindan Atlas Kanzou. Bunkodo, Tokyo, 22-27. (In Japanese)
[19]  Matsui, O., Kadoya, M., Kameyama, T., et al. (1991) Benign and Malignant Nodules in Cirrhotic Livers: Distinction Based on Blood Supply. Radiology, 178, 493-497.
https://doi.org/10.1148/radiology.178.2.1846240
[20]  Asayama, Y., Yoshimitsu, K., Nishihara, Y., et al. (2008) Arterial Blood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic-Pathologic Correlation. AJR American Journal of Roentgenology, 190, W28-W34.
https://doi.org/10.2214/AJR.07.2117
[21]  Li, C.S., Chen, R.C., Tu, H.Y., et al. (2006) Imaging Well-Differentiated Hepatocellular Carcinoma with Dynamic Triple-Phase Helical Computed Tomography. The British Journal of Radiology, 79, 659-665.
https://doi.org/10.1259/bjr/12699987
[22]  Karahan, O.I., Yikimaz, A., Isin, S., et al. (2003) Characterization of Hepatocellular Carcinomas with Triphasic CT and Correlation with Histopathologic Findings. Acta Radiologica, 44, 566-571.
https://doi.org/10.1080/02841850312331287839
[23]  Tamura, S., Kato, T., Berho, M., et al. (2001) Impact of Histological Grade of Hepatocellular Carcinoma on the Outcome of Liver Transplantation. Archives of Surgery, 136, 25-30.
https://doi.org/10.1001/archsurg.136.1.25
[24]  Tajima, T., Honda, H., Taguchi, K., et al. (2002) Sequential Hemodynamic Change in Hepatocellular Carcinoma and Dysplastic Nodules: CT Angiography and Pathologic Correlation. AJR American Journal of Roentgenology, 178, 885-897.
https://doi.org/10.2214/ajr.178.4.1780885
[25]  Khemlina, G., Ikeda, S. and Kurzrock, R. (2017) The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies. Molecular Cancer, 16, Article No. 149.
https://doi.org/10.1186/s12943-017-0712-x
[26]  Niu, Z.S., Niu, X.J. and Wang, W.H. (2016) Genetic Alterations in Hepatocellular Carcinoma: An Update. World Journal of Gastroenterology, 22, 9069-9095.
https://doi.org/10.3748/wjg.v22.i41.9069
[27]  Oishi, K., Itamoto, T., Amano, H., et al. (2007) Clinicopathologic Features of Poorly Differentiated Hepatocellular Carcinoma. Journal of Surgical Oncology, 95, 311-316.
https://doi.org/10.1002/jso.20661
[28]  Park, H.S., Lee, J.M., Kim, S.H., et al. (2009) Differentiation of Well-Differentiated Hepatocellular Carcinomas from Other Hepatocellular Nodules in Cirrhotic Liver: Value of SPIO-Enhanced MR Imaging at 3.0 Tesla. Journal of Magnetic Resonance Imaging, 29, 328-335.
https://doi.org/10.1002/jmri.21615
[29]  Sugimoto, K., Moriyasu, F., Kamiyama, N., et al. (2008) Correlation between Parametric Imaging Using Contrast Ultrasound and the Histological Differentiation of Hepatocellular Carcinoma. Hepatology Research, 38, 273-280.
https://doi.org/10.1111/j.1872-034X.2007.00259.x
[30]  Bansal, S., Gui, J., Merrill, C., et al. (2019) Contrast-Enhanced US in Local Ablative Therapy and Secondary Surveillance for Hepatocellular Carcinoma. Radiographics, 39, 1302-1322.
https://doi.org/10.1148/rg.2019180205
[31]  Imai, Y., Murakami, T., Hori, M., et al. (2007) Hypervascular Hepatocellular Carcinoma: Combined Dynamic MDCT and SPIO-Enhanced MRI versus Combined CTHA and CTAP. Hepatology Research, 38, 147-158.
https://doi.org/10.1111/j.1872-034X.2007.00210.x
[32]  Tsurusaki, M., Sugimoto, K., Fujii, M., et al. (2007) Combination of CT during Arterial Portography and Double-Phase CT Hepatic Arteriography with Multi-Detector Row Helical CT for Evaluation of Hypervascular Hepatocellular Carcinoma. Clinical Radiology, 62, 1189-1197.
https://doi.org/10.1016/j.crad.2007.05.005

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133